Brief: Tanvex Biopharma Announces Merger Plan With Unit Of Bora Pharmaceuticals
27/08/2024 09:43
Aug 27 (Reuters) - Tanvex Biopharma 6541.TW :
* ANNOUNCES MERGER PLAN WITH UNIT OF BORA PHARMACEUTICALS
6472.TW
* TANVEX THE PLANNED MERGER WOULD BE ACHIEVED VIA 1:1 STOCK
SWAP
* TANVEX SAYS THE PLANNED MERGER IS SUBJECT TO REGULATORY
APPROVAL
Source text for Eikon: ID:nMOP1YGG8D
Further company coverage: 6541.TW
(Reporting by Faith Hung)
((faith.hung@thomsonreuters.com;))
Recent news on Tanvex Biopharma
See all newsBrief: Tanvex Biopharma Announces Merger Plan With Unit Of Bora Pharmaceuticals
Brief: Tanvex Biopharma Says 2023 Net Loss At T$2.14 Bln
Brief: Tanvex Biopharma Says Board Approves Plan To Invest Up To $5 Mln In Taiwan Unit
Brief: Tanvex Biopharma Says 9-Month Net Loss At T$1.62 Bln
Brief: Tanvex Biopharma to issue 25 mln new shares for working capital supplement